Jim Keon, President of the CGPA, discusses how the Canadian generics industry is adapting to the current period of political transition and how it…

Jim Keon, Preisdent of CGPA, discusses the cost-saving benefits that generic drugs have offered Canada, and offers his insights into Canada’s…